Glenmede Trust’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$486K Buy
15,097
+2,348
+18% +$83.4K ﹤0.01% 972
2025
Q4
$459K Buy
+12,749
New +$468K ﹤0.01% 971
2025
Q1
$483K Sell
10,832
-50
-0.5% -$2.69K ﹤0.01% 921
2024
Q4
$598K Sell
10,882
-481
-4% -$24.3K ﹤0.01% 869
2024
Q3
$480K Buy
11,363
+108
+1% +$5.14K ﹤0.01% 945
2024
Q2
$516K Sell
11,255
-1,495
-12% -$70.5K ﹤0.01% 893
2024
Q1
$663K Buy
12,750
+1,194
+10% +$52.3K ﹤0.01% 830
2023
Q4
$412K Sell
11,556
-20
-0.2% -$697 ﹤0.01% 953
2023
Q3
$388K Sell
11,576
-226
-2% -$7.83K ﹤0.01% 918
2023
Q2
$346K Hold
11,802
﹤0.01% 941
2023
Q1
$346K Sell
11,802
-280
-2% -$8.11K ﹤0.01% 946
2022
Q4
$318K Sell
12,082
-50
-0.4% -$1.19K ﹤0.01% 972
2022
Q3
$281K Sell
12,132
-178
-1% -$4.86K ﹤0.01% 985
2022
Q2
$309K Sell
12,310
-1,490
-11% -$44K ﹤0.01% 992
2022
Q1
$527K Buy
13,800
+6,720
+95% +$242K ﹤0.01% 881
2021
Q4
$278K Sell
7,080
-3,694
-34% -$162K ﹤0.01% 1076
2021
Q3
$525K Buy
10,774
+4,907
+84% +$254K ﹤0.01% 894
2021
Q2
$308K Buy
+5,867
New +$334K ﹤0.01% 1024
2017
Q3
Sell
-25
Closed 2847
2017
Q2
$0 Hold
25
﹤0.01% 2694
2017
Q1
$0 Hold
25
﹤0.01% 2755
2016
Q4
$0 Hold
25
﹤0.01% 2624
2016
Q3
$0 Hold
25
﹤0.01% 2679
2016
Q2
$0 Hold
25
﹤0.01% 2713
2016
Q1
$0 Hold
25
﹤0.01% 2723
2015
Q4
$0 Hold
25
﹤0.01% 2777
2015
Q3
$0 Hold
25
﹤0.01% 2828
2015
Q2
$0 Buy
+25
New +$86 ﹤0.01% 2777

Other funds holding VCEL

Glenmede Trust's VCEL Position: Q1 2026 in Review

Glenmede Trust increased its Vericel Corp (VCEL) stake by 18% in Q1 2026, buying an estimated $83.4K and bringing the position to 15,097 shares worth $486K. The position accounts for ﹤0.01% of the portfolio, ranked #972.

Glenmede Trust first reported a position in VCEL in Q2 2015 and has held it in 27 quarters since. The position peaked at $663K in Q1 2024. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.

  • Glenmede Trust held 15,097 shares of Vericel Corp worth $486K as of Q1 2026.
  • Glenmede Trust bought 2,348 Vericel Corp shares in Q1 2026, an estimated $83.4K.
  • Vericel Corp made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #972 holding.
  • Glenmede Trust first reported a position in Vericel Corp in Q2 2015 and has held it in 27 quarters since.
  • Glenmede Trust's Vericel Corp position peaked at $663K in Q1 2024.
  • 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.